MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.74
+1.09 (5.03%)
At close: Dec 11, 2024, 4:00 PM
22.70
-0.04 (-0.18%)
After-hours: Dec 11, 2024, 5:11 PM EST

MBX Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Cash & Equivalents
132.8730.5224.21
Short-Term Investments
144.250.1518.25
Cash & Short-Term Investments
277.0680.6842.46
Cash Growth
552.51%90.00%-
Other Receivables
0.860.210.14
Receivables
0.860.210.14
Prepaid Expenses
2.412.451.52
Other Current Assets
0.840.130.08
Total Current Assets
281.1783.4744.21
Property, Plant & Equipment
1.180.670.84
Other Long-Term Assets
0.050.050.04
Total Assets
282.484.1845.1
Accounts Payable
51.390.98
Accrued Expenses
5.752.382.32
Current Portion of Leases
0.170.150.14
Total Current Liabilities
10.923.933.43
Long-Term Leases
0.040.170.32
Other Long-Term Liabilities
0.070.190.07
Total Liabilities
11.034.293.82
Common Stock
0.0100
Additional Paid-In Capital
393.183.050.41
Retained Earnings
-121.92-75.58-43.02
Comprehensive Income & Other
0.110.060
Total Common Equity
271.37-72.47-42.61
Shareholders' Equity
271.3779.8941.27
Total Liabilities & Equity
282.484.1845.1
Total Debt
0.210.320.46
Net Cash (Debt)
276.8580.3542
Net Cash Growth
559.17%91.31%-
Net Cash Per Share
20.116.565.24
Filing Date Shares Outstanding
33.4215.118.02
Total Common Shares Outstanding
33.3815.118.02
Working Capital
270.2579.5440.78
Book Value Per Share
8.13-4.80-5.31
Tangible Book Value
271.37-72.47-42.61
Tangible Book Value Per Share
8.13-4.80-5.31
Machinery
10.240.23
Construction In Progress
00-
Leasehold Improvements
0.390.370.35
Source: S&P Capital IQ. Standard template. Financial Sources.